VAIA
PRNB

Virtus Alternative Investment Advisers’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-215
Closed -$13K – 312
2020
Q2 		$13K Buy
+215
New +$13.3K 0.2% 224

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Virtus Alternative Investment Advisers's PRNB Position: Q3 2020 in Review

Virtus Alternative Investment Advisers sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 215 shares — an estimated $13K sold.

Virtus Alternative Investment Advisers first reported a position in PRNB in Q2 2020 and held it in 1 quarter. The position peaked at $13K in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Virtus Alternative Investment Advisers reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 215 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $13K.
  • Virtus Alternative Investment Advisers first reported a position in Principia Biopharma Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Virtus Alternative Investment Advisers's Principia Biopharma Inc. Common Stock position peaked at $13K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Virtus Alternative Investment Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.